Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04017845Phase 1Completed
Phase 1, single-blind trial (2 arms). Primary endpoints: Prevalence of causes accounting for population disagreement to participate in screening programme, Prevalence of CRC risk factors and risk stratification in target population and 2 more. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04017845.